Skip to content
Screener

Rivian Automotive, Inc. RIVN Testing Milestone Payments — Proceeds from stock-based compensation programs

Similar metrics at other companies

Tarsus Pharmaceuticals, Inc. logo
TARSSales-based Milestones — Maximum milestone payments
$4M
Fox Factory Holding Corp. logo
FOXFPayments for (Proceeds from) Stock Compensation Program
$1.18M+103%
Climb Bio, Inc. logo
CLYMSales Milestones — Milestone Payments
$8M
Tarsus Pharmaceuticals, Inc. logo
TARSCommercial and Sales Milestones — Maximum milestone payments
$77M0.0%
ROP
ROPProceeds from (tax withholding payments for) stock-based compensation, net
$2.3M-92.6%
Tarsus Pharmaceuticals, Inc. logo
TARSClinical Milestones — Contractual milestone payment net sales
$500K

Other financials

Income statement

See full
Revenue$1.7B+27.2%
Gross profit$119.0M-42.2%
Operating income-$881.0M-34.5%
Net income-$833.0M+25.4%
EPS (diluted)-$0.63+35.1%

Balance sheet

See full
Cash & equivalents$2.8B-39.4%
Total debt$5.2B+7.5%
Total equity$4.4B-28.9%
Total assets$14.2B-8.2%

Cash flow

See full
Operating cash flow-$703.0M-274%
CapEx$372.0M+10.1%
Free cash flow-$1.1B-104%

Valuation

See full
Market cap$22.53B+59.5%
Enterprise value$24.92B+47.8%
P/S3.8×+1.1×

Profitability

See full
Gross margin1%
Operating margin-68.9%-6.6pp
Net margin-55%-8.9pp
FCF margin-55%

Returns & leverage

See full
Return on equity-66%+19.4pp
Debt / equity1.2×+0.4×
Current ratio2.1×-1.6×

Where this comes from

Reported directly by Rivian Automotive, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The source filing: Rivian Automotive, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001874178-26-000035

In connection with the formation of Rivian and Volkswagen Group Technologies, LLC (the “Joint Venture”), the Company and Volkswagen-US Holding, Inc. (formerly known as Volkswagen International America, Inc.) (“VW”) and Volkswagen Aktiengesellschaft (“VW AG” and together with VW and their respective affiliates, “Volkswagen Group”) entered into an investment agreement (“Investment Agreement”) for additional equity investments in the Company, including an investment pursuant to the achievement of the Testing Milestones defined in the Investment Agreement. The Testing Milestones were achieved in March 2026, and on April 30, 2026 the Company received $1,000 million in exchange for approximately 63 million shares of the Company’s Class A common stock, calculated based on its 30-trading day volume-weighted average price prior to share issuance (i.e., $15.90 per share).

Item 1. Financial Statements (unaudited)

FAQ

What is Rivian Automotive, Inc.'s testing milestone payments — proceeds from stock-based compensation programs?
Rivian Automotive, Inc. (RIVN) reported testing milestone payments — proceeds from stock-based compensation programs of $1B in Q2 2026.
What does testing milestone payments — proceeds from stock-based compensation programs mean?
Represents the cash inflows generated from the exercise of stock options or the purchase of shares through employee stock purchase plans specifically attributed to the testing and development milestone segment. This metric reflects the liquidity impact of equity-based incentive programs on the company's capital structure. It serves as a measure of employee participation in equity ownership and the resulting cash generation for the business unit.

Ask your AI about Rivian Automotive, Inc.'s testing milestone payments — proceeds from stock-based compensation programs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude